삼성서울병원

Ko En

소화기내과 강원석 교수

진료분야
간암, 간경화, 급성간염, 만성간염, 지방간, 간이식, 간질환
진료일정 06 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 07 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2013.02 한국과학기술원(KAIST) 의과학대학원 박사
2009.02 연세대학교 의과대학 대학원 석사
2004.02 연세대학교 의과대학 의학과

경력

경력
2021.09 ~현재 성균관대학교 의과대학 내과학교실 부교수
2022.08 ~ 2023.07 The Jackson Laboratory for Genomic Medicine 연수
2016.03 ~ 2021.08 성균관대학교 의과대학 내과학교실 조교수
2015.09 ~ 2016.02 삼성서울병원 소화기내과 진료조교수
2015.03 ~ 2015.08 세브란스병원 연구조교수
2014.03 ~ 2015.02 세브란스병원 임상조교수
2013.05 ~ 2014.02 세브란스병원 임상강사
2013.03 ~ 2013.04 한국과학기술원 위촉연구원
2009.02 ~ 2013.02 한국과학기술원(KAIST) 전문연구요원
2005.03 ~ 2009.02 세브란스병원 레지던트
2004.03 ~ 2005.02 세브란스병원 인턴
  • JHEP REP 2023 10.1016/j.jhepr.2023.100810 Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma Song, BG; Choi, SC; Goh, MJ; Kang, WS; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
    View PubMed
  • MOL THER-ONCOLYTICS 2023 10.1016/j.omto.2023.08.013 Transgenic viral expression of PH-20, IL-12, and sPD1-Fc enhances immune cell infiltration and anti-tumor efficacy of an oncolytic virus Hong, SO; Kim, J; Lee, SM; Shin, J; Choi, H; Lee, EJ; Kang, HYS; Lee, HYS; Lee, SD; Yun, N; An, JW; Choi, H; Kim, H; Kang, WS; Yoon, Y; Kim, S
    View PubMed
  • LIVER INT 2023 10.1111/liv.15632 Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII Song, BG; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW; Sinn, DH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-36668-2 Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B Oh, JH; Park, Y; Goh, MJ; Sinn, DH; Ahn, SB; Kang, WS; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
    View PubMed
  • OBESITY 2023 10.1002/oby.23722 Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study Kim, MS; Song, M; Kim, S; Kim, B; Kang, W; Kim, JY; Myung, W; Lee, I; Do, R; Khera, AV; Won, HH
    View PubMed
  • GUT LIVER 2023 10.5009/gnl220420 Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study Chang, JI; Kim, JH; Sinn, DH; Cho, JY; Kim, KM; Oh, JH; Park, Y; Sohn, W; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • EUR J GASTROEN HEPAT 2023 10.1097/MEG.0000000000002466 Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma Kim, Y; Lee, JS; Lee, HW; Kim, BK; Park, JY; Kim, D; Ahn, SH; Goh, MJ; Kang, W; Kim, SU
    View PubMed
  • LIVER CANCER 2023 10.1159/000529635 Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors Goh, MJ; Park, HC; Yu, JI; Kang, WS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Sinn, DH; Choi, MS
    View PubMed
  • GUT LIVER 2023 10.5009/gnl220337 Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis Goh, MJ; Kim, J; Chang, WH; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Kang, WS
    View PubMed
  • LIVER CANCER 2022 10.1159/000525145 Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study Casadei-Gardini, A; Rimini, M; Kudo, M; Shimose, S; Tada, T; Suda, G; Goh, MJ; Jefremow, A; Scartozzi, M; Cabibbo, G; Campani, C; Tamburini, E; Tovoli, F; Ueshima, K; Aoki, T; Iwamoto, H; Torimura, T; Kumada, T; Hiraoka, A; Atsukawa, M; Itobayashi, E; Toyoda, H; Sakamoto, N; Sho, T; Kang, W; Siebler, J; Neurath, MF; Burgio, V; Cascinu, S
    View PubMed
  • HEPATOL RES 2022 10.1111/hepr.13824 Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib Rimini, M; Kang, W; Burgio, V; Persano, M; Aoki, T; Shimose, S; Tada, T; Kumada, T; Sho, T; Lai, E; Celsa, C; Campani, C; Tonnini, M; Tamburini, E; Hiraoka, A; Takaguchi, K; Nishida, N; Iwamoto, H; Itobayashi, E; Tsuji, K; Sakamoto, N; Ishikawa, T; Toyoda, H; Kudo, M; Kawaguchi, T; Hatanaka, T; Nouso, K; Suda, G; Cabibbo, G; Marra, F; Della Corte, A; Ratti, F; Pedica, F; De Cobelli, F; Aldrighetti, L; Scartozzi, M; Cascinu, S; Casadei-Gardini, A
    View PubMed
  • SCAND J GASTROENTERO 2022 10.1080/00365521.2022.2093124 Imaging features of hepatobiliary MRI and the risk of hepatocellular carcinoma development Chang, JI; Sinn, DH; Jeong, WK; Hwang, JA; Won, HY; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-022-14856-w Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease Park, JH; Hong, JY; Han, K; Kang, W; Park, JK
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-022-11736-1 Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy Goh, MJ; Kang, W; Jeong, WK; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • KOREAN J INTERN MED 2022 10.3904/kjim.2021.452 Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea Song, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.888755 Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis Yu, JI; Kang, W; Yoo, GS; Goh, MJ; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Hong, JY; Lim, HY; Park, B; Park, HC
    View PubMed
  • CLIN MOL HEPATOL 2022 10.3350/cmh.2022.0084 KASL clinical practice guidelines for management of chronic hepatitis B Jang, JW; Park, JY; Kwon, JH; Yu, SJ; Kang, W; Chon, YE; Kim, TH; Choi, J; An, JY
    View PubMed
  • GENOME MED 2022 10.1186/s13073-021-00995-8 Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial Hong, JY; Cho, HJ; Sa, JK; Liu, XQ; Ha, SY; Lee, T; Kim, H; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, HC; Kang, TW; Rhim, H; Lee, SJ; Cristescu, R; Lee, J; Paik, YH; Lim, HY
    View PubMed
  • EUR J GASTROEN HEPAT 2022 10.1097/MEG.0000000000001915 Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase Seong, G; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • J GASTROEN HEPATOL 2021 10.1111/jgh.15727 Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma Kim, BH; Yu, SJ; Kang, W; Cho, SB; Park, SY; Kim, SU; Kim, D
    View PubMed
  • DIGEST DIS SCI 2021 10.1007/s10620-021-07312-8 Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels Chang, JI; Sinn, DH; Cho, H; Kim, S; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ESMO OPEN 2021 10.1016/j.esmoop.2021.100330 Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib Rimini, M; Kudo, M; Tada, T; Shigeo, S; Kang, W; Suda, G; Jefremow, A; Burgio, V; Iavarone, M; Tortora, R; Marra, F; Lonardi, S; Tamburini, E; Piscaglia, F; Masi, G; Cabibbo, G; Foschi, FG; Silletta, M; Kumada, T; Iwamoto, H; Aoki, T; Goh, MJ; Sakamoto, N; Siebler, J; Hiraoka, A; Niizeki, T; Ueshima, K; Sho, T; Atsukawa, M; Hirooka, M; Tsuji, K; Ishikawa, T; Takaguchi, K; Kariyama, K; Itobayashi, E; Tajiri, K; Shimada, N; Shibata, H; Ochi, H; Yasuda, S; Toyoda, H; Fukunishi, S; Ohama, H; Kawata, K; Tani, J; Nakamura, S; Nouso, K; Tsutsui, A; Nagano, T; Takaaki, T; Itokawa, N; Okubo, T; Arai, T; Imai, M; Joko, K; Koizumi, Y; Hiasa, Y; Cucchetti, A; Ratti, F; Aldrighetti, L; Cascinu, S; Casadei-Gardini, A
    View PubMed
  • SCAND J GASTROENTERO 2021 10.1080/00365521.2021.1988700 Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B Goh, MJ; Kang, W; Kim, KM; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J NEUROGASTROENTEROL 2021 10.5056/jnm20221 Proton Pump Inhibitor Use Increases Pyogenic Liver Abscess Risk: A Nationwide Cohort Study Oh, JH; Kang, D; Kang, W; Guallar, E; Cho, J; Min, YW
    View PubMed
  • J VIRAL HEPATITIS 2021 10.1111/jvh.13572 Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response Na, JE; Sinn, DH; Lee, JH; Jang, HJ; Baek, SY; Kim, KA; Kang, WS; Gwak, GY; Paik, YH; Kim, YJ; Choi, MS; Yoon, JH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOL INT 2021 10.1007/s12072-021-10205-7 Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy Oh, JH; Lee, HW; Sinn, DH; Park, JY; Kim, BK; Kim, SU; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • HEPATOLOGY 2021 10.1002/hep.32034 The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study Park, Y; Sinn, DH; Oh, JH; Goh, MJ; Kim, K; Kang, W; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Gwak, GY
    View PubMed
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2021.03.030 Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure Kim, JE; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J CLIN APHERESIS 2021 10.1002/jca.21873 Initial experience with high-volume plasma exchange in patients with acute liver failure Kim1, JE; Chun, S; Sinn, DH; Kim, NJ; Kim, S; Kang, W; Kim, JM; Choi, GS; Joh, JW; Cho, D
    View PubMed
  • EUR J CANCER 2021 10.1016/j.ejca.2021.03.024 Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study Park1, JH; Hong, JY; Kwon, M; Lee, J; Han, K; Han, IW; Kang, W; Park, JK
    View PubMed
  • J HEPATOCELL CARCINO 2021 10.2147/JHC.S304439 Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study Cho1, YY; Yu, SJ; Lee, HW; Kim, DY; Kang, W; Paik, YH; Sung, PS; Bae, SH; Park, SC; Doh, YS; Kim, KM; Jang, ES; Kim, IH; Kim, W; Kim, YJ
    View PubMed
  • NUTRIENTS 2021 10.3390/nu13031013 Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease Oh1, JH; Lee, JH; Cho, MS; Kim, H; Chun, J; Lee, JH; Yoon, Y; Kang, W
    View PubMed
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2020.10.030 A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients Song1, BG; Kim, MJ; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J GASTROEN HEPATOL 2021 10.1111/jgh.15357 Metabolic activity assessment by F-18-fluorodeoxyglucose positron emission tomography in patients with hepatocellular carcinoma undergoing Yttrium-90 transarterial radioembolization Kim1, D; Lee, HW; Kang, W; Kim, GM; Won, JY; Yun, M
    View PubMed
  • LIVER CANCER 2021 10.1159/000512239 Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea Goh1, MJ; Oh, JH; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLIN MOL HEPATOL 2021 10.3350/cmh.2020.0095 Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study Yoo1, GS; Ahn, WG; Kim, SY; Kang, W; Choi, C; Park, HC
    View PubMed
  • CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2021 10.14309/ctg.0000000000000290 Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance Park1, Y; Lee, JH; Sinn, DH; Park, JY; Kim, MA; Kim, YJ; Yoon, JH; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.1.12 Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma Lee1, JS; Chon, YE; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Han, KH; Kang, W; Choi, MS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Kim, HY; Kim, TH; Yoo, K; Ha, Y; Kim, MN; Lee, JH; Hwang, SG; Kim, SS; Cho, HJ; Cheong, JY; Cho, SW; Park, SH; Heo, NY; Hong, YM; Yoon, KT; Cho, M; Park, JG; Kang, MK; Park, SY; Kweon, YO; Tak, WY; Jang, SY; Sinn, DH; Kim, SU
    View PubMed
  • SCAND J GASTROENTERO 2020 10.1080/00365521.2020.1866063 Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance potential implications for surveillance goal Song1, JH; Goh, MJ; Park, Y; Oh, JH; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0016 Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238 Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria Oh1, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • DIGEST DIS SCI 2020 10.1007/s10620-020-06591-x Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events Oh1, JH; Goh, MJ; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • DIGEST DIS SCI 2020 10.1007/s10620-020-06533-7 Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization A Nationwide, Multi-center, Retrospective Cohort Study Hyun1, HK; Cho, EJ; Park, SY; Hong, YM; Kim, SS; Kim, HY; Heo, NY; Park, JG; Sinn, DH; Kang, W; Jeong, SW; Song, MJ; Park, H; Lee, D; Lee, YS; Cho, SB; An, CS; Rhee, HJ; Lee, HW; Kim, BK; Park, JY; Kim, D; Ahn, SH; Han, KH; Lee, JH; Yu, SJ; Kim, YJ; Yoon, JH; Tak, WY; Kweon, YO; Yoon, KT; Cho, M; Cheong, JY; Park, SH; Kim, SU
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13279 Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients Kim1, J; Chung, SJ; Sinn, DH; Lee, KW; Park, JB; Huh, W; Lee, JE; Jang, HR; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ALIMENT PHARM THER 2020 10.1111/apt.15741 Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase Lee1, HA; Lee, HW; Kim, IH; Park, SY; Sinn, DH; Yu, JH; Seo, YS; Um, SH; Lee, JI; Lee, KS; Lee, CH; Tak, WY; Kweon, YO; Kang, W; Paik, YH; Lee, JW; Suh, SJ; Jung, YK; Kim, BK; Park, JY; Kim, Y; Ahn, SH; Han, KH; Yim, HJ; Kim, SU
    View PubMed
  • TRANSPL P 2020 10.1016/j.transproceed.2020.01.037 Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma Song1, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Joh, JW; Choi, GS
    View PubMed
  • VIRUSES-BASEL 2020 10.3390/v12030302 The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses Shin1, EC; Han, JW; Kang, W; Kato, T; Kim, SJ; Zhong, J; Kim, S; Park, SH; Sung, PS; Watashi, K; Park, JY; Windisch, MP; Oh, JW; Wakita, T; Han, KH; Jang, SK
    View PubMed
  • J GASTROINTEST SURG 2020 10.1007/s11605-020-04540-7 Incidence of and Risk Factors for Alcohol Relapse After Liver Transplantation for Alcoholic Liver Disease: Comparison Between Deceased Donor and Living Donor Liver Transplantation Chung1, HG; Sinn, DH; Kang, W; Choi, GS; Kim, JM; Joh, JW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.040 Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.196 Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance Kim1, HK; Kang, W; Sinn, DH; Lee, JH; Kim, WS; Kim, SJ
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14750 Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0213547 Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment? Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0210730 Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
    View PubMed
  • STEM CELL RES THER 2019 10.1186/s13287-018-1127-3 The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis Park1, S; Hwang, SI; Kim, J; Hwang, S; Kang, S; Yang, S; Kim, J; Kang, W; Kim, KH; Han, DW; Paik, YH
    View PubMed
  • EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226 Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895 Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment? Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6 Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • CARDIOVASC INTER RAD 2017 10.1007/s00270-017-1751-9 Ultrasound-Guided Radiofrequency Ablation Using a New Electrode with an Electromagnetic Position Sensor for Hepatic Tumors Difficult to Place an Electrode: A Preliminary Clinical Study Kang1, TW; Lee, MW; Song, KD; Rhim, H; Lim, HK; Kang, W; Kim, K
    View PubMed
  • DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8 Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOLOGY 2017 10.1002/hep.28916 Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • GUT LIVER 2017 10.5009/gnl16403 A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • J Vasc Res. 2016;53(1-2):72-82. Epub 2016 Sep 20. Antiangiogenic Therapy Induces Hepatic Tumor Vascular Network Rearrangement to Receive Perfusion via the Portal Vein and Hepatic Artery Kang W11, Lim JS, Park MS, Koh GY, Kim H.
    View PubMed